Physician profile
Nitin Malik
NPI 1912360306
$2,792.95
in general payments reported to CMS, 2019-2025
6 companies · $2,373 in 2025
The $2,373 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $337 · 2023: $63.59 · 2024: $18.69 · 2025: $2,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,040 · Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,040.04 |
| Food and Beverage | $415.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,410.56 | 2022-2025 | Triclip |
| Philips North America LLC | $262.53 | 2022-2025 | Holter |
| Heartflow, INC. | $40.43 | 2023 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.51 | 2024-2025 | Lifevest |
| Edwards Lifesciences Corporation | $23.16 | 2023 | Sapien 3 Ultra Resilia |
| Amgen INC. | $18.76 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nitin Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.